Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
buy vibrator.
Popular Articles

Faster, Cheaper Genome Sequencing Featured At The 15-Minute Genome 2009 Industrial Physics Forum
In the race for faster, cheaper ways to read human genomes, Pacific Biosciences is hoping to set a new benchmark with technology that watches DNA being copied in real time. The device is being developed to sequence DNA at speeds 20,000 times faster than second-generation sequencers currently on the market and will ultimately have a price tag of $100 per genome.
pharmacy online
What Is Dandruff? What Causes Dandruff?
Dandruff affects the scalp and causes flakes of skin to appear - it is a common condition. Our skin cells are forever renewing themselves. When the skin cells on our scalp are renewed the old ones are pushed to the surface and out of the scalp. For a person with dandruff the renewal is faster, meaning more dead skin is shed, making the dandruff more noticeable. Dandruff can also occur if the scalp is frequently exposed to extreme temperatures. Dandruff is also known as scurf - its medical term is Pityriasis capitis.
News of the day
MicroPhage Results On Rapid S. Aureus/MRSA Blood Culture Test Published
The performance of a new diagnostic test platform that rapidly identifies Staphylococcus aureus (S. aureus, "staph") bacteremia and determines antibiotic resistance or susceptibility in as little as five hours was presented at the 109th General Meeting of the American Society of Microbiology in Philadelphia, PA this week.
Medical Devices

Radiant Research, Inc. Prepares For Upcoming H1N1 Vaccine Trials

Radiant Research, Inc. announced that it is actively recruiting subjects and establishing operational plans for upcoming H1N1 vaccine trials. The World Health Organization declared the H1N1 influenza outbreak a pandemic, and the CDC has shipped virus samples to several manufacturers with the hope of having vaccine available to the general public by the fall. Manufacturers will need to complete clinical trials prior to release of vaccine to the public. "Our research sites are ideal for this type of clinical trial," said Julie McHugh, Vice President of Late Phase Clinical Research, Radiant Research, Inc. "We have conducted over 200 vaccine trials and enrolled thousands of subjects into these trials in the past five years. We know how to enroll these trials quickly and efficiently, and we enforce the standards that ensure quality data collection." "We have over a million subjects in our database and they are both familiar with the research process and very interested in this type of trial," said Michael Kritschgau, Vice President of Radiant Recruitment. "We are currently making contact with these potential subjects so we can be ready to enroll once the manufacturers are ready to move to the clinical trials stage. We anticipate that companies producing the vaccine will soon be reaching out to various research. Radiant Research, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009